Clinical trial

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

NCT00019695

Study summary

ClinicalTrials.gov

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record alendronate sodium Normalized identity: alendronate sodium View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record ketoconazole Normalized identity: ketoconazole View linked drug · Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date1999-03-01

PhasePHASE2

Conditions

Stage IV Prostate Cancerunresolved

Bone Metastasesunresolved

Adenocarcinoma of the Prostateverified · MONDO: prostate adenocarcinoma

Recurrent Prostate Cancerunresolved

Interventions

alendronate sodiumDRUG · verified · RxNorm: alendronate sodium

ketoconazoleDRUG · verified · RxNorm: ketoconazole

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00019695 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.